JANX Latest Press Releases

-- January 26, 2026 --

Janux Therapeutics Appoints William Go, M.D., Ph.D., as Chief Medical Officer Business Wire 7:00 AM

-- January 22, 2026 --

Janux Therapeutics Announces Collaboration and Exclusive Worldwide License Agreement with Bristol Myers Squibb to Develop a Novel Tumor-Activated Therapeutic for Solid Tumors Business Wire 7:00 AM

-- December 23, 2025 --

Janux Therapeutics Provides Program Update on Ongoing Phase 1 JANX008 Study Business Wire 4:05 PM

-- December 1, 2025 --

Janux Announces Encouraging Efficacy and Safety Profile from Ongoing Phase 1 Clinical Trial for JANX007 in mCRPC Business Wire 4:05 PM

-- November 24, 2025 --

Janux Therapeutics to Host Virtual Event Discussing Updated Phase 1a and Phase 1b Clinical Data for JANX007 in mCRPC Business Wire 8:00 AM

-- November 6, 2025 --

Janux Therapeutics Reports Third Quarter 2025 Financial Results and Business Highlights Business Wire 4:01 PM

Market Data Delayed 15 Minutes

Questions? Feedback?Olark live chat software